Chengqiang Li
Papers
9
Total Citations
181
H-Index
5
About
Chengqiang Li is a pioneering thoracic surgeon whose research centers on robotic-assisted surgery for lung cancer and esophageal cancer, with a particular focus on non-small-cell lung cancer (NSCLC). His landmark contributions include leading the RVlob randomized controlled trial, which provided the first randomized evidence comparing robotic-assisted lobectomy (RAL) to video-assisted lobectomy (VAL) for resectable NSCLC, demonstrating comparable perioperative outcomes and long-term survival. His highly cited 2021 study on robotic-assisted versus video-assisted thoracoscopic lobectomy, with 116 citations, further solidified the safety and efficacy of robotic approaches. Li has also advanced complex techniques such as robotic sleeve resection and combined anatomic pulmonary subsegmentectomy, showcasing the feasibility of minimally invasive surgery for challenging pulmonary diseases. His work extends to esophageal cancer, where he has reviewed and refined robot-assisted Ivor Lewis esophagectomy techniques. With recent studies exploring single-port robotic systems, Li continues to push the boundaries of thoracic surgery. His research, cited over 180 times, has established him as a key figure in the transition from traditional to robotic-assisted thoracic oncology, offering patients safer, less invasive options while maintaining oncologic rigor.
Research Focus
Key Achievements
Top Papers
- 1Robotic-assisted Versus Video-assisted Thoracoscopic Lobectomy116 citations · 2021
- 2
- 3Robotic sleeve resection for pulmonary disease17 citations · 2018
- 4
- 5
- 6
- 7
- 8Robotic-assisted thoracoscopic segmentectomy: there is a long way to go2 citations · 2017
- 9